WSJournal. Pain Pills' Littlest Victims Mothers on

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone

WSJournal. Pain Pills' Littlest Victims

Mothers on Oxycodone Give Birth to Drug-Dependent Babies; 'It's Heartbreaking'

http://online.wsj.com/article/SB10001424127887324731304578193642361543484.html?mod=ITP_pageone_1

VIDEO: CLick on Hospitals in Florida and elsewhere are grappling with the latest fallout from the epidemic of prescription-drug abuse: babies born addicted to painkillers. The newborns present new challenges for hospitals. Photo: Jason Henry/The Wall Street Journal

SARASOTA, Fla.—Hospitals around the country are confronting an unsettling consequence of the prescription-pain-pill epidemic: a surge in the number of babies born dependent on drugs such as oxycodone.

............................................................................................................................................................

One recent morning a 12-day-old girl lay writhing in the neonatal intensive-care unit at Sarasota Memorial Hospital. Erin Weatherwax, a nurse, tried to console the newborn by holding her against her chest and patting the baby's back. She placed the girl in a motorized swing that made cricket sounds. But the infant continued to squirm, unable to sleep more than a few minutes at a time.

The baby suffered withdrawal from methadone, a drug used to treat painkiller addiction that her mother took during pregnancy. The hospital sated the baby's physical cravings by giving her morphine as well as phenobarbital, a barbiturate used to treat seizures. Now she had to be weaned off those drugs.

Born Dependent on Opioids

Jason Henry for The Wall Street Journal

Eight hours after Gabriel was born, he exhibited a variety of withdrawal symptoms, including stiffened muscles and excessive sucking.

"It's heartbreaking," Ms. Weatherwax said.

Between 2000 and 2009, the number of newborns showing symptoms of withdrawal from drugs called opioids—including painkillers like oxycodone and antiaddiction drugs such as methadone—tripled in the U.S., according to a study published earlier this year in the Journal of the American Medical Association.

In 2009, more than 13,000 babies in the U.S. were diagnosed with the condition, formally known as neonatal abstinence syndrome, the study said.

The newborns—reminiscent of the "crack babies" of the 1980s and 1990s born to women addicted to cocaine—present a host of challenges to hospitals. There is no standard way to treat their withdrawal, so doctors and nurses are improvising to figure out the most effective combination of drugs and dosages.

The babies require constant attention, and their stays in a neonatal intensive care unit, or NICU, can stretch for weeks, tying up hospital resources. Their treatment is costly—a mean of $53,400—according to the JAMA study, and Medicaid covers the tab for 78% of the babies. Hospital charges to care for such infants jumped to an estimated $720 million in 2009 from $190 million in 2000, the study said.

[image]

Hospitals in states such as Kentucky and West Virginia have reported a sharp rise in the number of opioid-dependent babies. In Florida, long the nation's epicenter of illegal prescription-drug sales, the problem is acute, especially in a cluster of counties near Tampa Bay, including Sarasota. Hospitals such as Spring Hill Regional Hospital, north of Tampa, said that as many as 30% of the babies in their NICUs suffer from opioid withdrawal.

Hospitals were ill-prepared for the drug-dependent infants. "This isn't a problem I learned about in training," said Terri Ashmeade, medical director of the NICU and chief of pediatrics at Tampa General Hospital. Her unit, like others, relied at first on protocols for heroin withdrawal in babies, mainly using phenobarbital, she said. But the staff quickly found that withdrawal symptoms for today's painkillers, which are powerful and long-acting, were much more severe.

The newborns cry incessantly, jerk their limbs and vomit. They can have such severe diarrhea that it burns the skin off their bottoms. Though treating them with the very opioids they are withdrawing from may seem jarring, doctors say the alternative could be worse: seizures and even death.

After years of trying different treatments, Tampa General settled on a uniform approach three months ago. Like many hospitals, it relies on a system that assigns points for different symptoms, and it initiates drug treatment if the numbers cross a certain threshold. (There is no blood test or other diagnostic to determine whether a baby is drug-dependent.)

Eight hours after he was born, Gabriel, a baby undergoing treatment recently at Tampa General's NICU, exhibited a variety of symptoms, including stiffened muscles and excessive sucking. So the hospital gave him methadone and, when the symptoms persisted, increased the doses until he reached the maximum. Two days later, he was still scoring high, so the hospital gave him clonidine, a drug used to treat withdrawal in adults.

At eight days, Gabriel was still taking the maximum dosage of methadone and close to the maximum of clonidine. He appeared mostly calm, but startled and trembled at times. It would likely take weeks more to wean him off the drugs, nurses said.

Sixty miles to the south, Sarasota Memorial is following a different protocol. While using the same scoring system, it starts babies on morphine, and if necessary, adds phenobarbital.

Hospitals have no choice but to experiment, given the paucity of research on what treatments are most effective. The American Academy of Pediatrics in February published new guidelines for neonatal abstinence syndrome—its first update since 1998. Though the paper cited a range of potential treatments, it didn't recommend one particular protocol.

To try to come up with a standard regimen, a collaborative of Florida hospitals, including Sarasota Memorial, plans to compare various approaches. Each NICU will rely on morphine and clonidine, but at different dosages, increased and decreased at different rates, said Mark Hudak, a neonatologist at Wolfson Children's Hospital in Jacksonville, which is part of the group. The group hopes to assemble its findings some time next year.

One objective is to cut down the amount of time babies are spending in intensive care and assess whether they are being overmedicated, Mr. Hudak said.

Hospitals are grappling with another concern: They worry they aren't catching all the affected babies. Not every mother is forthcoming about using prescription painkillers, which leaves it up to medical staff to look out for symptoms. Most newborns are discharged within 48 to 72 hours, yet babies exposed to long-acting opioids like methadone can take five or more days to show signs of withdrawal.

"Some are going home and withdrawing," said Tony Napolitano, medical director at Sarasota Memorial. And a mother with dependency issues may not be equipped to handle a highly irritable and sensitive newborn, he said.

Organizations like the Healthy Start Coalition of Hillsborough County, a nonprofit, are urging obstetricians to broach the subject of opioid use with their patients. Many don't, often because they are unaware how widespread the problem is, said Executive Director Jane Murphy.

Because the phenomenon of opioid-exposed babies is so new, little is known about any long-term effects. Some studies suggest they are at greater risk of attention deficit hyperactivity disorder, but the findings aren't conclusive.

Fears that the "crack babies" of decades past would develop severe physical, mental and emotional disabilities proved to be unfounded, research showed. But prescription-drug exposure "seems to be affecting babies' physiologies more than cocaine," said Ms. Ashmeade, the Tampa General neonatologist.

Write to Arian Campo-Flores at arian.campo-flores@wsj.com

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 7

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 7

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 5

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 4

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 3

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 3

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 5

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading

Top 5 Most Recently Viewed Articles

Reworld-SEMASS Sanitation Workers Unite with Teamsters Local 59

Updated Category News Views 219

Reworld-SEMASS Workers Unionize for a Stronger Future 120 Sanitation Workers Organize with Local 59 for Strong Union Contract Recently, sanitation workers at Reworld-SEMASS made a significant move by voting to join Teamsters Local 59. This decision reflects the collective desire of 120 auxiliary operators, equipment operators, loader operators, and rail tippers to secure...

Continue Reading
Euroseas Ltd. Secures Year-Long Charter for M/V Jonathan P

Updated Category News Views 106

Euroseas Ltd. Announces New Charter Agreement Euroseas Ltd. (NASDAQ: ESEA), an established operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, is thrilled to announce the signing of a significant time charter for their 1,732 teu feeder containership, known as M/V Jonathan P. This new contract spans a duration of 11 to...

Continue Reading
Impact of Leadership Changes at SEC on Crypto Industry Future

Updated Category News Views 179

Shifts in SEC Leadership and Their Potential Impact on Cryptocurrency The cryptocurrency industry is facing anticipated changes as discussions about the future of the Securities and Exchange Commission (SEC) unfold. According to insights shared by Pantera Capital's chief legal officer, Katrina Paglia, significant changes may occur once Gary Gensler steps down from his...

Continue Reading
Terra Innovatum Global Anticipates Key Financial Update Soon

Updated Category News Views 111

Anticipation Builds for Terra Innovatum Global’s Financial Results Terra Innovatum Global N.V. (NASDAQ: NKLR), a pioneer in the micro-modular nuclear reactor space, is gearing up to unveil its third quarter financial results for the fiscal year 2025. This eagerly awaited announcement is set to take place just before the start of trading on an upcoming Monday. Who Will...

Continue Reading
Magnachip Semiconductor Expands Production of Next-Gen MOSFETs

Updated Category News Views 180

Magnachip's Expansion in MOSFET Production Magnachip Semiconductor Corporation (NYSE: MX) is significantly advancing its production capabilities with the latest expansion of its 7th generation MXT LV MOSFETs. This strategic move aligns perfectly with the rising demand for compact and efficient low voltage MOSFETs utilized in a variety of advanced mobile devices today....

Continue Reading